In her bi-weekly column, “State of the Territory,” former Sen. Janelle K. Sarauw delves deeper into issues of concern for V.I. residents.
As a former senator and an impassioned citizen deeply invested in the well-being of our community, I find it imperative to cast a spotlight on a critical aspect of our healthcare system that often lurks in the shadows yet yields far-reaching implications for those in desperate need of timely medical care. The issue at hand is the labyrinthine pre-authorization process embedded within CIGNA insurance agreements—a concern I vehemently raised during my tenure in the Senate. This intricate web of negotiations, obscured from effective oversight, significantly hampers our ability to address deficiencies in the pre-authorization process, leaving patients stranded in a bureaucratic quagmire.
The Pre-Authorization Process: Unveiling Complexity
Delving into the convoluted realm of the pre-authorization process with CIGNA unveils a multifaceted journey intricately woven into the fabric of our healthcare landscape. Before certain treatments and medications can be administered, the daunting hurdle of prior approval from the health insurance carrier must be cleared. This process, while intended to align with medical best practices and cost-effectiveness, often introduces unwarranted delays and complications.
Breaking down the pre-authorization process reveals a crucial sequence of events:
- Submission of Request: When a healthcare provider recommends a treatment or medication that falls under the umbrella of prior authorization, a request is submitted to the insurance carrier. This step is essential for obtaining approval before proceeding with the recommended care.
- Response Timeline: Typically, within 5-10 business days of receiving the prior authorization request, the insurance company responds with one of the following:
a. Approval: The request is granted, allowing the patient to proceed with the recommended treatment or medication.
b. Denial: The request is denied, necessitating a reevaluation of the proposed care plan.
c. Additional Information Request: The insurance company may ask for more information to make an informed decision regarding the authorization request.
d. Alternative Recommendation: In some cases, the insurance company may recommend trying an alternative treatment or medication that is equally effective but less costly.
3. Clinical Review: These responses are the outcome of a meticulous review process conducted by clinical pharmacists and medical doctors employed by the health insurance company. Their expertise ensures that decisions are informed by medical best practices, cost considerations, and a commitment to providing quality care.
A Personal Encounter: Urgency Ignored
The gravity of this issue hit home when a dear friend faced a triple-negative breast cancer diagnosis. Following National Comprehensive Cancer Network guidelines, essential diagnostic tests were promptly ordered. However, the pre-authorization process with CIGNA introduced significant delays, jeopardizing the timely delivery of critical healthcare services. Such delays are unacceptable, especially in cases where swift responses are imperative for effective patient care.
CIGNA’s policy allows for a 5-10 business day window to authorize complex medical procedures. The question arises: if a procedure is deemed complex, does it not warrant swift approval rather than prolonged waiting periods? The addition of a peer-to-peer review, ultimately resulting in approval, raises concerns about the necessity of such bureaucratic hurdles.
The Heart of the Matter: A Call for Urgent Reform
The core issue is crystal clear: patients, particularly those battling serious illnesses like cancer, should not bear the burden of a labyrinthine pre-authorization process that obstructs their access to timely care. It falls upon the Government Employees Service Commission Board to reevaluate and revamp the current system, placing the well-being of our citizens at the forefront.
If the pre-authorization process is to persist, a more efficient turnaround time—ideally within 24 hours—should be implemented. The present system, with its protracted waiting periods and unnecessary reviews, only serves to hinder the delivery of prompt and essential healthcare services. Our citizens deserve a healthcare system that is not only effective but also compassionate, providing the care they need precisely when they need it.
The call for reform is urgent, and the onus is on the Government Employees Service Commission Board to heed this plea. The health and well-being of our citizens depend on the responsiveness and efficiency of our healthcare systems. It is time to put patient care first and ensure that our healthcare processes align with the urgency that serious medical conditions demand.
